Syria Receives Its First Delivery of Covid-19 Vaccine through COVAX

Amman: Syria has received 256,800 doses of the covid-19 vaccine, the first COVAX delivery of vaccines to reach the war-torn country. 
 
This delivery of AstraZeneca vaccines (from the Serum Institute of India) will be given to frontline health workers across Syria, including the northeast and northwest.
 
“The delivery is a ray of light for the people of Syria. It will help health workers to continue delivering life-saving services in an already exhausted health system as a result of the decade-long war," said WHO, Gavi the Vaccine Alliance, and UNICEF in a press release on Thursday.

The covid-19 vaccines were delivered today through two shipments: 203,000 doses arrived in Damascus while another 53,800 doses were delivered to the northwest, an area that continues to witness armed conflict and people’s displacement. 
 
More deliveries are planned for Syria in the coming weeks and months.
 
"To date, Syria has recorded 51,580 cases of covid-19. The actual number is likely to be much higher due to limited or unavailability of testing supplies. This makes the delivery of vaccines critical and timely. Much more support is needed to help Syria’s health workers wherever they are in the country and its most at-risk population including the elderly and those with underlying health conditions to get the vaccines against this virus," they stated.
 
Since March 3, the COVAX facility has delivered more than 5 million doses to the Middle East and North Africa. 
 
In addition to today’s delivery to Syria, the facility reached 18 countries in total including Iran, Iraq, Lebanon, the State of Palestine, Sudan and Yemen among other conflict-affected and fragile countries”.
 
COVAX is the vaccine facility of the Access to covid-19 Tools Accelerator (ACT-A), a ground-breaking global collaboration to accelerate development, production, and equitable access to covid-19 diagnostics, treatments, and vaccines.

 
Cek Berita dan Artikel yang lain di Google News